These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26852162)

  • 41. Reactive oxygen species damaged human serum albumin in patients with type 1 diabetes mellitus: biochemical and immunological studies.
    Rasheed Z; Ali R
    Life Sci; 2006 Nov; 79(24):2320-8. PubMed ID: 16945391
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Identification of modification sites on human serum albumin and human hemoglobin adducts with houttuynin using liquid chromatography coupled with mass spectrometry.
    Deng Z; Zhong D; Chen X
    Biomed Chromatogr; 2012 Nov; 26(11):1377-85. PubMed ID: 22334394
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mass spectrometric monitoring of albumin in uremia.
    Thornalley PJ; Argirova M; Ahmed N; Mann VM; Argirov O; Dawnay A
    Kidney Int; 2000 Nov; 58(5):2228-34. PubMed ID: 11044246
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of different glycation agents on Cu(II) binding to human serum albumin, studied by liquid chromatography, nitrogen microwave-plasma atomic-emission spectrometry, inductively-coupled-plasma mass spectrometry, and high-resolution molecular-mass spectrometry.
    Corrales Escobosa AR; Wrobel K; Yanez Barrientos E; Jaramillo Ortiz S; Ramirez Segovia AS; Wrobel K
    Anal Bioanal Chem; 2015 Feb; 407(4):1149-57. PubMed ID: 25428457
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antibody enrichment and mass spectrometry of albumin-Cys34 adducts.
    Chung MK; Grigoryan H; Iavarone AT; Rappaport SM
    Chem Res Toxicol; 2014 Mar; 27(3):400-7. PubMed ID: 24328277
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Enhanced recognition of reactive oxygen species damaged human serum albumin by circulating systemic lupus erythematosus autoantibodies.
    Rasheed Z; Ahmad R; Rasheed N; Ali R
    Autoimmunity; 2007 Nov; 40(7):512-20. PubMed ID: 17966041
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Oxidative damage of albumin in advanced liver disease.
    Oettl K; Stadlbauer V; Petter F; Greilberger J; Putz-Bankuti C; Hallström S; Lackner C; Stauber RE
    Biochim Biophys Acta; 2008; 1782(7-8):469-73. PubMed ID: 18498776
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Relative quantification of albumin and fibrinogen modifications by liquid chromatography tandem mass spectrometry in the diagnosis and monitoring of acute pancreatitis.
    Lankes U; Brennan SO; Walmsley TA; George PM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2015 Apr; 988():121-6. PubMed ID: 25770789
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oxidative stresses induced by glycoxidized human or bovine serum albumin on human monocytes.
    Rondeau P; Singh NR; Caillens H; Tallet F; Bourdon E
    Free Radic Biol Med; 2008 Sep; 45(6):799-812. PubMed ID: 18616999
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Human serum albumin, systemic inflammation, and cirrhosis.
    Arroyo V; García-Martinez R; Salvatella X
    J Hepatol; 2014 Aug; 61(2):396-407. PubMed ID: 24751830
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Active focal segmental glomerulosclerosis is associated with massive oxidation of plasma albumin.
    Musante L; Candiano G; Petretto A; Bruschi M; Dimasi N; Caridi G; Pavone B; Del Boccio P; Galliano M; Urbani A; Scolari F; Vincenti F; Ghiggeri GM
    J Am Soc Nephrol; 2007 Mar; 18(3):799-810. PubMed ID: 17287427
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Capillary zone electrophoresis and capillary electrophoresis-mass spectrometry for analyzing qualitative and quantitative variations in therapeutic albumin.
    Marie AL; Przybylski C; Gonnet F; Daniel R; Urbain R; Chevreux G; Jorieux S; Taverna M
    Anal Chim Acta; 2013 Oct; 800():103-10. PubMed ID: 24120174
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Investigation of albumin properties in patients with chronic renal failure.
    Pieniazek A; Brzeszczynska J; Kruszynska I; Gwozdzinski K
    Free Radic Res; 2009 Oct; 43(10):1008-18. PubMed ID: 19707919
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Albumin in chronic liver disease: structure, functions and therapeutic implications.
    Spinella R; Sawhney R; Jalan R
    Hepatol Int; 2016 Jan; 10(1):124-32. PubMed ID: 26420218
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival.
    Oettl K; Birner-Gruenberger R; Spindelboeck W; Stueger HP; Dorn L; Stadlbauer V; Putz-Bankuti C; Krisper P; Graziadei I; Vogel W; Lackner C; Stauber RE
    J Hepatol; 2013 Nov; 59(5):978-83. PubMed ID: 23811308
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Contribution of superoxide to reduced antioxidant activity of glycoxidative serum albumin.
    Sakata N; Moh A; Takebayashi S
    Heart Vessels; 2002 Nov; 17(1):22-9. PubMed ID: 12434198
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and quantification of drug-albumin adducts in serum samples from a drug exposure study in mice.
    Switzar L; Kwast LM; Lingeman H; Giera M; Pieters RH; Niessen WM
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 Feb; 917-918():53-61. PubMed ID: 23353939
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidation and carboxy methyl lysine-modification of albumin: possible involvement in the progression of oxidative stress in hemodialysis patients.
    Mera K; Anraku M; Kitamura K; Nakajou K; Maruyama T; Tomita K; Otagiri M
    Hypertens Res; 2005 Dec; 28(12):973-80. PubMed ID: 16671336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Determination of protein binding rate of oleanolic acid in human plasma and serum albumin].
    Zhang H; Zhang HF; Chang HC; Han X; Bi KS; Chen XH
    Yao Xue Xue Bao; 2011 Feb; 46(2):243-6. PubMed ID: 21542298
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Guanidinylations of albumin decreased binding capacity of hydrophobic metabolites.
    Rueth M; Lemke HD; Preisinger C; Krieter D; Theelen W; Gajjala P; Devine E; Zidek W; Jankowski J; Jankowski V
    Acta Physiol (Oxf); 2015 Sep; 215(1):13-23. PubMed ID: 25939450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.